Corticotropin-releasing factor-2 activation prevents gentamicin-induced oxidative stress in cells derived from the

Johnvesly Basappa1, Sevin Turcan, Douglas E Vetter

  • 1Department of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.

Insights

Corticotropin-releasing factor (CRF) signaling via CRF(2) receptors protects cochlear cells from oxidative stress and cell death caused by aminoglycosides. This reveals a novel protective mechanism against hearing loss.

Area of Science:

  • Oto-neurology
  • Cellular biology
  • Molecular mechanisms of hearing loss

Background:

  • Reactive oxygen species (ROS) contribute to cochlear cell death.
  • Endogenous mechanisms protecting the cochlea from oxidative stress are poorly understood.
  • A corticotropin-releasing factor (CRF) signaling system in the inner ear influences noise-induced hearing loss.

Purpose of the Study:

  • To investigate the role of CRF signaling in cochlear cell response to aminoglycoside exposure.
  • To define the protective mechanisms of CRF signaling against aminoglycoside-induced ototoxicity.

Main Methods:

  • Biochemical assays
  • Proteomics analysis
  • Assessment of ROS production
  • Evaluation of cell death pathways

Main Results:

  • CRF signaling, specifically through CRF(2) receptors, protects against aminoglycoside-induced ROS production.
  • CRF(2) receptor activity inhibits aminoglycoside-induced activation of cell death pathways.
  • Proteomics data suggest novel protective mechanisms beyond free radical scavengers.

Conclusions:

  • CRF signaling plays a protective role in the cochlea against oxidative stress.
  • CRF(2) receptor activation is a key component in mitigating aminoglycoside ototoxicity.
  • This study uncovers new molecular pathways involved in cochlear protection from oxidative damage.

Related Concept Videos